Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Sakthivel, Priya ^a   Gereke, Marcus ^a,b   Breithaupt, Angele ^c   Fuchs, Dietmar ^d   Gigliotti, Luca ^e   Gruber, Achim D ^c   Dianzani, Umberto ^e   Bruder, Dunja ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE T CELL COSTIMULATOR; INDUCIBLE T CELL COSTIMULATOR AGONIST; INDUCIBLE T CELL COSTIMULATOR ANTIBODY; INTERLEUKIN 10; RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOINTERSTITIAL PNEUMONIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE BLOOD LEVEL; FEMALE; IMMUNE MEDIATED INFLUENZA PNEUMONIA; IMMUNOPATHOLOGY; INFLUENZA A; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS ATTENUATION; VIRUS PNEUMONIA; AGONISTS; ANIMAL; COMPLICATION; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MOLECULARLY TARGETED THERAPY; ORTHOMYXOVIRUS INFECTION; PNEUMONIA; PROCEDURES; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERLEUKIN-10; LUNG; MICE; MOLECULAR TARGETED THERAPY; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA;

EID: 84904277981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100970     Document Type: Article

References (53)

1. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, et al. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397: 263-266.
2. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, et al. (1999) T-cell co-stimulation through B7RP-1 and ICOS. Nature 402: 827-832. (Pubitemid 129638129)
3. Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, et al. (2000) Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96: 2808-2813.
4. Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, et al. (2001) ICOS costimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101. (Pubitemid 32098632)
5. Kopf M, Coyle AJ, Schmitz N, Barner M, Oxenius A, et al. (2000) Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 192: 53-61. (Pubitemid 30470806)
6. Fu T, He Q, Sharma P (2011) The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy. Cancer Res 71: 5445-5454.
7. Nurieva RI, Treuting P, Duong J, Flavell RA, Dong C (2003) Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest 111: 701-706. (Pubitemid 36278588)
8. Scott BG, Yang H, Tüzün E, Dong C, Flavell RA, et al. (2004) ICOS is essential for the development of experimental autoimmune myasthenia gravis. J Neuroimmunol 153: 16-25. (Pubitemid 38950923)
9. Paulos CM, Carpenito C, Plesa G, Suhoski MM, Varela-Rohena A, et al. (2010) The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci Transl Med 2: 55ra78.
10. Gao X, Gigoux M, Yang J, Leconte J, Yang X, et al. (2012) Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling. PLoS One 7: e52657.
11. Mesturini R, Gigliotti CL, Orilieri E, Cappellano G, Soluri MF, et al. (2013) Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1. Cytokine 64: 322-330.
12. Dong C, Temann UA, Flavell RA (2001) Cutting edge: critical role of inducible costimulator ingerminal center reactions. J Immunol 166: 3659-3662. (Pubitemid 32224886)
13. Wong SC, Oh E, Ng CH, Lam KP (2003) Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2. Blood 102: 1381-1388. (Pubitemid 36988047)
14. Mittrücker HW, Kursar M, Köhler A, Yanagihara D, Yoshinaga SK, et al. (2002) Inducible costimulator protein controls the protective T cell response against Listeria monocytogenes. J Immunol 169: 5813-5817. (Pubitemid 35291684)
15. Vidric M, Bladt AT, Dianzani U, Watts TH (2006) Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice. Infect Immun 74: 1050-1061. (Pubitemid 43185542)
16. Klingenberg R, Autschbach F, Gleissner C, Giese T, Wambsganss N, et al. (2005) Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent alloactivation of CD8+ T cells in vitro. Eur J Immunol 35: 1712-1721. (Pubitemid 40862319)
17. Khayyamian S, Hutloff A, Büchner K, Gräfe M, Henn V, et al. (2002) ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A 99: 6198-6203. (Pubitemid 34493289)
18. Ito T, Yang M, Wang YH, Lande R, Gregorio J, et al (2007) Plasmacytoid dendritic cells prime IL-10 producing T regulatory cells by inducible costimulator ligand. J Exp Med 204: 105-115. (Pubitemid 46148761)
19. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, et al (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 8: 1024-1032. (Pubitemid 35033708)
20. McGee HS, Edwan JH, Agrawal DK (2010) Flt3-L Increases CD4+CD25+ FoxP3+ ICOS+ Cells in the Lung of Cockroach-sensitized and Challenged Mice. Am J Respir Cell Mol Biol 42: 331-340.
21. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, et al. (2008) Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28: 870-880.
22. Kohyama M, Sugahara D, Sugiyama S, Yagita H, Okumura K, et al. (2004) Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc Natl Acad Sci U S A 101: 4192-4197. (Pubitemid 38405905)
23. Gotsman I, Grabie N, Gupta R, Dacosta R, MacConmara M, et al. (2006) Impaired Regulatory T cell response and enhanced atheroscleorosis in the absence of inducible co-stimulatory molecules. Circulation 114: 2047-2055. (Pubitemid 44706881)
24. Herman AE, Freeman GJ, Mathis D, Benoist C (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199: 1479-1489. (Pubitemid 38780403)
25. Honkanen J, Skarsvik S, Knip M, Vaarala O (2008) Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes. Diabetes Metab Res Rev 24: 635-641.
26. Busse M, Krech M, Meyer-Bahlburg A, Hennig C, Hansen G (2012) ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance. J Immunol 189: 1975-1982.
27. Marks E, Verolin M, Stensson A, Lycke N (2007) Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection. Infect Immun 75: 4638-4647. (Pubitemid 47378125)
28. Wilson EH, Zaph C, Mohrs M, Welcher A, Siu J, et al. (2006) B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses. J Immunol 177: 2365-2372. (Pubitemid 44200997)
29. Greenwald RJ, McAdam AJ, Van der Woude D, Satoskar AR, Sharpe AH (2002) Cutting edge: Inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. J Immunol 168: 991-995. (Pubitemid 34094460)
30. Humphreys IR, Edwards L, Snelgrove RJ, Rae AJ, Coyle AJ, et al. (2006) A critical role for ICOS co-stimulation in immune containment of pulmonary influenza virus infection. Eur J Immunol 36: 2928-2938. (Pubitemid 44782567)
31. Nouailles G, Day TA, Kuhlmann S, Loewe D, Dorhoi A, et al. (2011) Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection. Eur J Immunol 41: 981-991.
32. Bertram EM, Tafuri A, Shahinian A, Chan VS, Hunziker L, et al. (2002) Role of ICOS versus CD28 in antiviral immunity. Eur J Immunol 32: 3376-3385. (Pubitemid 36024375)
33. Redoglia V, Dianzani U, Rojo JM, Portolés P, Bragardo M, et al. (1996) Characterization of H4: a mouse T lymphocyte activation molecule functionally associated with the CD3/T cell receptor. Eur J Immunol 26: 2781-2789. (Pubitemid 26364859)
34. Gereke M, Gröbe L, Prettin S, Kasper M, Deppenmeier S, et al. (2007) Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation. Respir Res 8: 47.
35. Telieps T, Ewald F, Gereke M, Annemann M, Rauter Y, et al. (2013) c-FLIPR modulates cell death induction upon T-cell activation and infection. Eur J Immunol 43: 1499-1510.
36. Laich A, Neurauter G, Widner B, Fuchs D (2002) More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 48: 579-581. (Pubitemid 34174597)
37. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, et al. (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 3: 873-876. (Pubitemid 20330669)
38. Wallin JJ, Liang L, Bakardjiev A, Sha WC (2001) Enhancement of CD8+ T cell responses by ICOS/B7h costimulation. J Immunol 167: 132-139. (Pubitemid 32567770)
39. Liu X, Bai XF, Wen J, Gao JX, Liu J, et al. (2001) B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J Exp Med 194: 1339-1348. (Pubitemid 33055051)
40. Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, et al. (2006) Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells. J Immunol 176: 7394-7401. (Pubitemid 43849041)
41. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, et al. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-117. (Pubitemid 27499863)
42. Redpath SA, van der Werf N, Cervera AM, MacDonald AS, Gray D, et al. (2013) ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur J Immunol 43: 705-715.
43. Kornete M, Sgouroudis E, Piccirillo CA (2012) ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188: 1064-1074.
44. Quiroga MF, Pasquinelli V, Martínez GJ, Jurado JO, Zorrilla LC, et al. (2006) Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol 176: 5965-5974.
45. Pfaff AW, Mousli M, Sénégas A, Marcellin L, Takikawa O, et al. (2008) Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection. Int J Parasitol 38: 249-258. (Pubitemid 350284614)
46. Fox JM, Sage LK, Huang L, Barber J, Klonowski KD, et al. (2013) Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection. J Gen Virol 94: 1451-1461.
47. Liu XS, Dyer J, Leggatt GR, Fernando GJ, Zhong J, et al. (2006) Overcoming original antigenic sin to generate new CD8 T cell IFN-gamma responses in an antigen- experienced host. J Immunol 177: 2873-2879. (Pubitemid 44277802)
48. Liu XS, Xu Y, Hardy L, Khammanivong V, Zhao W, et al. (2003) IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host. J Immunol 171: 4765-4772. (Pubitemid 37310595)
49. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT (2003) CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198: 889-901. (Pubitemid 37152926)
50. Turner DL, Bickham KL, Farber DL, Lefrançois L (2013) Splenic priming of virus-specific CD8 T cells following influenza virus infection. J Virol 87: 4496-4506.
51. + regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection. PLoS One 6: e27849.
52. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31: 475-527.
53. Bertram EM, Dawicki W, Watts TH (2004) Role of T cell costimulation in antiviral immunity. Semin Immunol 16: 185-196. (Pubitemid 38569899)